Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06745895 · ClinicalTrials.gov registry record · NA

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening

A NA study of Colorectal Cancer Screening and Hepatitis C Virus, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Recruiting
Registry status
NA
Development phase
350
Enrollment target
1
Study location

NCT06745895 is a NA study of Colorectal Cancer Screening and Hepatitis C Virus that is actively recruiting participants, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 350 participants, below the 5,864-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06745895, a NA study of Colorectal Cancer Screening and Hepatitis C Virus, is actively recruiting participants, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

RECRUITING
Registry status
NA
Development phase
350 participants
Enrollment target
1
Study location

Study Summary

This innovative Multilevel Action Toward Colorectal Cancer (CRC) and Hepatitis C Virus (HCV) Education and Screening (MATCHES) intervention aims to promote concurrent HCV and CRC screening among FQHC patients ages 45-75.

Interventions

  • BEHAVIORAL MATCHES

Study Locations (1)

Florida

  • Moffitt Cancer Center - Tampa

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2024-10-21
Est. Completion 2028-04-30
Phase NA

What the Registry Record Tells You About NCT06745895

The ClinicalTrials.gov registry entry for NCT06745895 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,864-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (94% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which MATCHES is the first listed.

NCT06745895 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06745895 about?

NCT06745895 is a clinical study titled "Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening". This innovative Multilevel Action Toward Colorectal Cancer (CRC) and Hepatitis C Virus (HCV) Education and Screening (MATCHES) intervention aims to promote concurrent HCV and CRC screening among FQHC patients ages 45-75.

What is the current status of trial NCT06745895?

This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2024-10-21. Estimated completion is 2028-04-30.

What conditions does trial NCT06745895 study?

This clinical trial studies the following conditions: Colorectal Cancer Screening, Hepatitis C Virus.

What interventions are being tested in trial NCT06745895?

The interventions under investigation include: MATCHES (BEHAVIORAL).

Who is sponsoring clinical trial NCT06745895?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06745895 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.